Neoadjuvant Androgen Deprivation, Darolutamide, and Ipatasertib in Men With Localized, High Risk Prostate Cancer
Clinical trial NCT04737109 · TERMINATED
Trial details
- NCT number
- NCT04737109
- Sponsor
- David VanderWeele
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-13
- Primary completion
- 2022-08-15
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.